http://www.foxbusiness.com/markets/2015/07/20/tekmira-stops-work-on-ebola-drug-and-will-change-name-to-arbutus-as-it-focuses/
>One of the companies that had been studying a potential treatment for the Ebola virus said Monday it will suspend its research on Ebola drugs and change its name.
>Tekmira Pharmaceuticals Corp. said last month that an experimental Ebola treatment that it was developing would probably fail in a clinical trial. The Canadian company says it will focus on experimental treatments for the hepatitis B virus and will change its name to Arbutus Biopharma Corp.
>Tekmira said it will suspend work on its drug TKM-Ebola and is re-evaluating its development contract with the U.S. Department of Defense. The company said in June that a related drug, TKM-Ebola-Guinea, would probably fail in a mid-stage clinical trial. The drug is designed to block genes that help the virus reproduce and spread.
Emphasis mine. This marks a great victory for Ebola-chan. Tekmira Pharmaceuticals is going so far to wash its hands of its failures as sell itself off to another company. Now they're taking a swing at poor Hepatitis-chan.